# B7-H3 NIR Imaging for Osteosarcoma Surgery

> **NCT06778603** · PHASE1,PHASE2 · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Osteosarcoma
- Resection Margins
- B7-H3 Probe
- Local Recurrence

## Interventions

- **DRUG:** a targeted probe B7H3-IRDye800CW

## Key facts

- **NCT ID:** NCT06778603
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06778603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06778603, "B7-H3 NIR Imaging for Osteosarcoma Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06778603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*